Goodwin, Covington shepherd Biogen's $1.8bn acquisition of rare disease drugmaker globallegalpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globallegalpost.com Daily Mail and Mail on Sunday newspapers.
Biogen to shut down controversial Alzheimer's drug Aduhelm apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago.
Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago.
Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago.